Talking Techniques | Hans Keirstead on precision therapeutics for cancer and science in politics

Hans Keirstead, CEO and Founder of Aivita Biomedical, speaks to Tristan Free, Digital Editor of BioTechniques. Hans delves into his company’s exciting new precision immunotherapy, currently undergoing phase II trials, and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.

If you were interested by this podcast and the precision therapeutics discussed, check out our upcoming BioTechniques Online Event: Advancing Precision Medicine 2019  and register for free today